Sensory Gating Impairments in Heavy Cannabis Users Are Associated With Altered Neural Oscillations

Behavioral Neuroscience

Volumn 123, Issue 4, 2009, Pages 894-904

  Edwards, Chad R ^a   Skosnik, Patrick D ^a   Steinmetz, Adam B ^a   O'Donnell, Brian F ^a   Hetrick, William P ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

auditory gating; beta; gamma; marijuana; P50; time frequency

Indexed keywords

CANNABINOID 1 RECEPTOR;

ADULT; ARTICLE; AUDITORY STIMULATION; CANNABIS ADDICTION; CONTROLLED STUDY; EVENT RELATED POTENTIAL; EVOKED AUDITORY RESPONSE; FEMALE; HIPPOCAMPUS; HUMAN; LATENT PERIOD; MALE; NEOCORTEX; STIMULUS RESPONSE; TASK PERFORMANCE;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; AUDITORY PERCEPTION; BRAIN; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MARIJUANA ABUSE; QUESTIONNAIRES; TIME FACTORS; YOUNG ADULT;

EID: 67949108185     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0016328     Document Type: Article

References (67)

1. Bacci A., Huguenard J.R., and Prince D.A. Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 431 (2004) 312-316
2. Başar E., Başar-Eroĝlu C., Karakaş S., and Schürmann M. Are cognitive processes manifested in event-related gamma, alpha, theta, and delta oscillations in the EEG?. Neuroscience Letters 259 (1999) 165-168
3. Başar-Eroĝlu C., and Başar E. A compound P300-40 Hz response of the cat hippocampus. International Journal of Neuroscience 60 (1991) 227-237
4. Bickford-Wimer P.C., Nagamoto H., Johnson R., Adler L.E., Egan M., Rose G.M., et al. Auditory sensory gating in hippocampal neurons: A model system in the rat. Biological Psychiatry 27 (1990) 183-1192
5. Blumenfeld L.D., and Clementz B.A. Response to the first stimulus determines reduced auditory evoked response suppression in schizophrenia: Single trials analysis using MEG. Clinical Neurophysiology 112 (2001) 1650-1659
6. Boutros N.N., Belger A., Campbell D., D'Souza C., and Krystal J. Comparison of four components of sensory gating in schizophrenia and normal subjects: A preliminary report. Psychiatry Research 88 (1999) 119-130
7. Boutros N.N., Bonnet K.A., Millana R., and Liu J.A. A parametric study of the N40 auditory evoked response in rats: Component definition. Biological Psychiatry 42 (1997) 1051-1059
8. Boutros N.N., and Kwan S.W. Test-retest reliability of the rat N40 auditory evoked response: Preliminary data. Psychiatry Research 81 (1998) 269-276
9. Boutros N., Trautner P., Rosburg T., Korzyukov O., Grunwald T., Schaller C., et al. Sensory gating in the human hippocampal and rhinol regions. Clinical Neurophysiology 116 (2005) 1967-1974
10. Braff D.L., Swerdlow N.R., and Geyer M.A. Gating and habituation deficits in the schizophrenia disorders. Clinical Neuroscience 3 (1995) 131-139
11. Bramon E., Rabe-Hesketh S., Sham P., Murray R., and Frangou S. Meta-analysis of the P300 and P50 waveforms in schicophrenia. Schizophrenia Research 70 (2004) 315-329
12. Brenner C.A., Edwards C.R., Carroll C.A., Kieffaber P.D., and Hetrick W.P. P50 and acoustic startle gating are not related in healthy participants. Psychophysiology 41 (2008) 702-708
13. Brockhaus-Dumke A., Mueller R., Faigle U., and Klosterkoetter J. Sensory gating revisited: Relation between brain oscillations and auditory evoked potentials in schizophrenia. Schizophrenia Research 99 (2008) 238-249
14. Budney A.J., Hughes J.R., Moore B.A., and Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. American Journal of Psychiatry 161 (2004) 1967
15. Cadenhead K.S., Light G.A., Geyer M.A., and Braff D.L. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. American Journal of Psychiatry 157 (2000) 55
16. Clementz B.A., Geyer M.A., and Braff D.L. P50 suppression among schizophrenia and normal comparison subjects: A methodological analysis. Biological Psychiatry 41 (1997) 1035-1044
17. Cohen J. Eta-squared and partial eta-squared in communication science. Human Communication Research 28 (1973) 473-490
18. Cohen J. Quantitative methods in psychology: A power primer. Psychological Bulletin 112 (1992) 155-159
19. Cunningham M.O., Whittington M.A., Bibbig A., Roopun A., LeBeau F.E.N., Vogt A., et al. A role for fast rhythmic bursting neurons in cortical gamma oscillations in vitro. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 7152-7157
20. Delorme A., and Makeig S. EEGLAB: An open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. Journal of Neuroscience Methods 134 (2004) 9-21
21. Dissanayake D.W.N., Zachariou M., Marsden C.A., and Mason R. Auditory gating in rat hippocampus and medial prefrontal cortex: Effect of the cannabinoid agonist WIN. Neuropharmacology 55 (2008) 1397-1404
22. Edwards C.R., and Skosnik P.D. Cerebellar-dependent learning as a neurobehavioral index of the cannabinoid system. Critical Reviews in Neurobiology (2007)
23. Eggan S.M., Hashimoto T., and Lewis D.A. Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Archives of General Psychiatry 65 (2008) 772
24. Eggan S.M., and Lewis D.A. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: A regional and laminar analysis. Cerebral Cortex 17 (2007) 175
25. Emrich H.M., Leweke M.F., and Schneider U. Towards a cannabinoid hypothesis of schizophrenia: Cognitive impairments due to dysregulation of the endogenous cannabinoid system. Pharmacology Biochemistry and Behavior 56 (1997) 803-807
26. Freedman R., Adler L.E., and Waldo M. Gating of the auditory evoked potential in children and adults. Psychophysiology 24 (1987) 223-227
27. Freedman R., Adler L., Walda M., Pachtman E., and Franks R. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia comparison of medicated and drug-free patients. Biological Psychiatry 18 (1983) 537
28. Giuffrida A., Leweke F.M., Gerth C.W., Schreiber D., Koethe D., Faulhaber J., et al. Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology 29 (2004) 2108-2114
29. Grunwald T., Boutros N.N., Pezer N., von Oertzen J., Fernández G., Schaller C., et al. Neuronal substrates of sensory gating within the human brain. Biological Psychiatry 53 (2003) 511-519
30. Haenschel C., Baldeweg T., Croft R.J., Whittington M., and Gruzelier J. Gamma and beta frequency oscillations in response to novel auditory stimuli: A comparison of human electroencephalogram (EEG) data with in vitro models. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 7645-7650
31. Hájos M., Hoffman W.E., and Kocsis B. Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: Relevance to schizophrenia. Biological Psychiatry 63 (2008) 1075-1083
32. Hájos N., Katona I., Naiem S.S., Mackie K., Ledent C., Mody I., et al. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. European Journal of Neuroscience 12 (2000) 3239-3249
33. Hanlon F., Miller G., Thomas R., Irwin J., Jones A., Moses S., et al. Distinct M50 and M100 auditory gating deficits in schizophrenia. Psychophysiology 42 (2005) 417-427
34. Hill E.L., Gallopin T., Ferezou I., Cauli B., Rossier J., and Schweitzer P. Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons. Journal of Neurophysiology 97 (2007) 2580-2589
35. Hong L.E., Buchanan R.W., Thaker G.K., Shepard P.D., and Summerfelt A. Beta (~16 Hz) frequency neural oscillations mediate auditory sensory gating in humans. Psychophysiology 45 (2008) 197-204
36. Hong L.E., Summerfelt A., McMahon R.P., Thaker G.K., and Buchanan R.W. Gamma/beta oscillation and sensory gating deficit in schizophrenia. NeuroReport 15 (2004) 155-159
37. Hong L.E., Summerfelt A., Mitchell B.D., McMahon R.P., Wonodi I., Buchanan R.W., et al. Sensory gating endophenotype based on its neural oscillatory pattern and heritability estimate. Archives of General Psychiatry 65 (2008) 1008-1016
38. Iversen L. Cannabis and the brain. Brain 126 (2003) 1252-1270
39. Johannesen J.K., Kieffaber P.D., O'Donnell B.F., Shekhar A., Evans J.D., and Hetrick W.P. Contributions of subtype and spectral frequency analyses to the study of P50 ERP amplitude and suppression in schizophrenia. Schizophrenia Research 78 (2005) 269-284
40. Karakas S., and Basar E. Early gamma response is sensory in origin: A conclusion based on cross-comparison of results from multiple experimental paradigms. International Journal of Psychophysiology 31 (1998) 13-31
41. Kopell N., Ermentrout G.B., Whittington M.A., and Traub R.D. Gamma rhythms and beta rhythms have different synchronization properties. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 1867-1872
42. Mayer, A. R., Hanlon, F. M., Franco, A. R., Teshiba, T. M., Thoma, R. J., Clark, V. P., et al. (in press). The neural networks underlying auditory sensory gating. NeuroImage
43. Korzyukov O., Pflieger M., Wagner M., Bowyer S., Rosburg T., Sundaresan K., et al. Generators of the introstania P50 response in auditory sensory gating. Neuroimage 35 (2007) 814-826
44. Kurthen M., Trautner P., Rosburg T., Grunwald T., Dietl T., Kühn K., et al. Towards a functional topography of sensory gating areas: Invasive P50 recording and electrical stimulation mapping in epiteps surgery candidates. Psychiatry Research: Neuroimaging 155 (2007) 121-133
45. Neylan T.C., Fletcher D.J., Lenoci M., McCallin K., Weiss D.S., Schoenfeld F.B., et al. Sensory gating in chronic posttraumatic stress disorder: Reduced auditory P50 suppression in combat veterans. Biological Psychiatry 46 (1999) 1656-1664
46. Olincy A., and Martin L. Diminished suppression of the P50 auditory evoked potential in bipolar disorder subjects with a history of psychosis. American Journal of Psychiatry 162 (2005) 43
47. Ong W.Y., and Mackie K. A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain. Neuroscience 92 (1999) 1177-1191
48. O'Donnell B., Hetrick W., Vohs J., Krishnan G.P., Carrol C.A., and Shekhar A. Neural synchronization deficits to auditory stimulation in bipolar disorder. Neuroreport 15 (2004) 1369-1372
49. Patrick G., Straumanis J.J., Struve F.A., Fitz-Gerald M.J., Leavitt J., and Manno J.E. Reduced P50 auditory gating response in psychiatrically normal chronic marihuana users: A pilot study. Biological Psychiatry 45 (1999) 1307-1312
50. Patrick G., and Struve F.A. Reduction of auditory P50 gating response in marihuana users: Further supporting data. Clinical Electroencephalography 31 (2000) 88-93
51. Patterson J.V., Hetrick W.P., Boutros N.N., Jin Y., Sandman C., Stern H., et al. P50 sensory gating ratios in schizophrenics and controls: A review and data analysis. Psychiatry Research 158 (2008) 226-247
52. Pope H.G., Gruber A.J., and Yurgelun-Todd D. Residual neuropsychologic effects of cannabis. Current Psychiatry Reports 3 (2001) 507-512
53. Porjesz B., Almasy L., Edenberg H.J., Wang K., Chorlian D.B., Foroud T., et al. Linkage disequilibrium between the beta frequency of the human EEG and a GABAA receptor gene locus. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 3729-3733
54. Reich C.G., Karson M.A., Karnup S.V., Jones L.M., and Alger B.E. Regulation of IPSP theta rhythm by muscarinic receptors and endocannabinoids in hippocampus. Journal of Neurophysiology 94 (2005) 4290-4299
55. Rentzsch J., Penzhom A., Kernbichler K., Plöckl D., Gómez-Carrillo de Casto A., Gallinat J., and Jockers-Scherübl M.C. Differential impact of heavy cannabis use on sensory gating in schizophrenia patients and otherwise healthy controls. Experimental Neurology 205 (2007) 241-249
56. Robbe D., Montgomery S.M., Thome A., Rueda-Orozco P.E., McNaughton B.L., and Buzsaki G. Cannabinoids reveal importance of spike timing coordination in hippocampal function. Nature Neuroscience 9 (2006) 1526-1533
57. Skosnik P., and Edwards C. Cerebellar-dependent learning as a neurobehavioral index of the cannabinoid system. Critical Reviews in Neurobiology 19 (2007) 29
58. Skosnik P.D., Krishnan G.P., Aydt E.E., Kuhlenshmidt H.A., and O'Donnell B.F. Psychophysiological evidence of altered neural synchronization in cannabis use: Relationship to schizotypy. American Journal of Psychiatry 163 (2006) 1798-1805
59. Skosnik P.D., Krishnan G.P., Vohs J.L., and O'Donnell B.F. The effect of cannabis use and gender on the visual steady state evoked potential. Clinical Neurophysiology 117 (2006) 144-156
60. Smith D., Boutres N., and Schwarzkopf S. Reliability of P50 auditory evoked potential indices of auditory gating. Psychophysiology 31 (1994) 495-502
61. Soltesz I., and Staley K. High times for memory: Cannabis disrupts temporal coordination among hippocampal neurons. Nature Neuroscience 9 (2006) 1461-1463
62. Trettel J., Fortin D.A., and Levine E.S. Endocannabinoid signaling selectively targets perisomatic inhibitory inputs to pyramidal neurons in juvenile mouse neocortex. Journal of Physiology 556 (2004) 95-107
63. Villares J. Chronic use of marijuana decreases cannabinoid receptor binding and mRNA expression in the human brain. Neuroscience 145 (2007) 323-334
64. von Stein A., Rappelsberger P., Sarnthein J., and Petsche H. Synchronization between temporal and parietal cortex during multimodal object processing in man. Cerebral Cortex 9 (1999) 137-150
65. Weisser R., Weisbrod M., Roehrig M., Rupp A., Schroeder J., and Scherg M. Is frontal lobe involved in the generation of auditory evoked P50?. NeuroReport 12 (2001) 3303-3307
66. Whittington M.A., Traub R.D., Faulkner H.J., Stanford I.M., and Jefferys J.G.R. Recurrent excitatory postsynaptic potentials induced by synchronized fast cortical oscillations. Proceedings of the National Academy of Sciences of the United States of America 94 (1997) 12198-12203
67. Wilson R., and Nicoll R.A. Endocannabinoid signaling in the brain. Science 296 (2002) 678-682